Umoja Biopharma
Umoja Biopharma develops in vivo CAR T cell therapies that generate cancer-fighting T cells directly in a patient’s body. Its therapies are designed to treat cancers while making treatment more accessible by avoiding the multi-week cell manufacturing required for ex vivo CAR T therapies.
Facts
- HQ
- Seattle, WA 98109
- Sectors
- Biotechnology Research
- Founded
- 2019
- Type
- Corporation Seattle business license
- Employees
- 254
- Registered name
- Umoja Biopharma Inc Seattle business license
- Members see funding amounts. .
Is this your organization? Claim it
Founders
-
Andy Scharenberg Executive Officer, Director, Co-founder & Chief Executive Officer
-
Michael Jensen Co-Founder
Executives
-
Nate Hardy Executive, Chief Financial Officer